Board of Directors
Dr. Hari Kumar Ph.D.
Dr. Hari Kumar is Chairman of the Board of Directors. He brings to Kinarus an extensive leadership background in the pharmaceutical industry. Dr. Kumar served at Roche as Global Head of Transplant Immunosuppressives. He was Chief Business Officer at Amira Pharmaceuticals and Chief Executive Officer of Adheron Therapeutics. In his career, Dr. Kumar oversaw the launch of the immunosuppressive, CellCept®, the Alzheimer’s drug, Aricept® and the gastric ulcer drug, Aciphex® and several biotech partnerships and acquisitions.
Dr. Alexander Bausch Ph.D., MTE (IMD)
Dr. Alexander Bausch serves as Chief Executive Officer and member of the Kinarus Board of Directors. Dr. Bausch has extensive commercial, development and executive leadership expertise from a 20 year career in the pharmaceutical industry.
Dr. Silvio Inderbitzin Ph.D.
Dr. Silvio Inderbitzin is a member of the Board of Directors and also an investor in Kinarus. Dr. Inderbitzin has held multiple senior positions in the pharmaceutical industry during the last 20 years.
Eugene Tierney is an experienced business strategist with achievements across the whole Pharma value chain. He spent several years as Head of Global Pharma Business Strategy with F. Hoffmann-La Roche, before assuming Therapeutic Area Leadership for Anti-infectives & Transplantation.
Mr. Roger Meier
Roger Meier is a co-founder of Kinarus and a member of the Board of Directors. He is the founder and owner of Clarena Ltd., a company that has been serving corporates and executives in the fields of corporate finance, change management, coaching and HR over many years.